0T1B4KC
Bypass Bladder to Ileocutaneous with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | 0 Medical and Surgical |
| Body System | T Urinary System |
| Operation | 1 Bypass |
| Body Part | B Bladder |
| Approach | 4 Percutaneous Endoscopic |
| Device | K Nonautologous Tissue Substitute |
| Qualifier | C Ileocutaneous |
Operation Definition
Altering the route of passage of the contents of a tubular body part
Procedure Overview
Bypass procedures in the urinary system reroute the flow of urine around a damaged, obstructed, or diseased segment so it can drain through a new path instead. Common examples include an ileal conduit or continent urinary diversion after bladder removal, a ureteroneocystostomy that reconnects a ureter to the bladder at a new site, or a yeloureteral bypass for a blocked ureteropelvic junction. These operations are performed when a tumor, stricture, chronic obstruction, or a failed bladder makes normal drainage unsafe, since backed-up urine can damage the kidneys or cause repeated infections.
Patients typically encounter these procedures alongside cancer treatment, after trauma, or when a congenital narrowing has caused progressive kidney damage. The new pathway may be temporary, to protect a healing repair, or permanent, when the original structure cannot be salvaged.
Anatomy & Axis Detail
Bladder
The bladder is the distensible reservoir that stores urine delivered by the ureters before voiding through the urethra, and bypass procedures on it typically reroute urine around a bladder that is obstructed, contracted, or otherwise unable to receive urine normally, most often due to outlet obstruction, severe fibrosis, or fistulous disease, without removing the bladder itself. This differs from diversion performed after cystectomy in that the bladder remains in place while a new inflow or outflow route is constructed, such as a conduit connecting a ureter to skin or bowel while bypassing a diseased portion of the bladder wall or neck. Because the bladder interacts with multiple structures, ureters, urethra, and pelvic floor, correct coding depends on identifying exactly which connection was bypassed and which conduit or structure now carries the urine instead.
Approach: Percutaneous Endoscopic
Percutaneous Endoscopic combines a puncture through skin or mucous membrane with insertion of an endoscope to visualize the procedure internally, as in laparoscopic cholecystectomy. It is distinguished from plain Percutaneous by the presence of scope-guided visualization, and from Via Natural or Artificial Opening Endoscopic by its route being a new puncture rather than an existing orifice or stoma.
Device: Nonautologous Tissue Substitute
Nonautologous Tissue Substitute refers to biologic material sourced from a donor or another species, such as an allograft or xenograft, used to replace a body part. It differs from Autologous Tissue Substitute by tissue origin outside the patient's own body, and from Synthetic Substitute by being biologic rather than manufactured material.
Qualifier: Ileocutaneous
Ileocutaneous designates a bypass that connects the ileum directly to the skin surface, creating an external drainage or diversion pathway, as in an ileostomy-type procedure. It signals that intestinal content is redirected outward rather than to another internal segment of bowel. It parallels Colocutaneous but applies specifically when the ileum, not the colon, is the segment involved.
Coding & Documentation
Coders assign Bypass when documentation confirms a new route was created "from" one urinary structure "to" another (or to the skin, as in a conduit), rather than a repair of the existing channel. The operative note must name both the bypass origin and the qualifier destination, since the seventh-character qualifier changes with the target (bladder, ileum, cutaneous, etc.). A frequent error is coding Bypass when the surgeon actually performed Repair or Dilation of an existing passage rather than constructing an alternate route; another is missing the correct device value when a stent or conduit segment is left in place.